Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Umbilical cord matrix, a rich new stem cell source, study shows

17.01.2003


The cushioning material or matrix within the umbilical cord known as Wharton’s jelly is a rich and readily available source of primitive stem cells, according to findings by a research team at Kansas State University.



Animal and human umbilical cord matrix cells exhibit the tell-tale characteristics of all stem cells, the capacity to self-renew and to differentiate into multiple cell types.

Researchers Kathy Mitchell, Deryl Troyer, and Mark Weiss of the College of Veterinary Medicine and Duane Davis of the College of Agriculture carried out the studies.


The cells -- called cord matrix stem cells to distinguish them from cord blood cells -- can be obtained in a non-invasive manner from an abundant source of tissue that is typically discarded.

According to Weiss and Troyer, "Umbilical cord matrix cells could provide the scientific and medical research community with a non-controversial and easily attainable source of stem cells for developing treatments for Parkinson’s disease, stroke, spinal cord injuries, cancers and other conditions."

A paper, "Matrix cells from Wharton’s jelly form neurons and glia," appears Jan. 16 in the on-line version of the journal "Stem Cells."

Among the findings: Wharton’s jelly cells from pigs were propagated in the lab for more than a year without losing potency; they can be stored cryogenically and engineered to express foreign proteins.

The cells exhibit telomerase activity, a key indicator of stem cells, and they can be induced to form nerve cells, both neurons and glia, that produce a range of nerve-cell specific traits. Neurons are the nervous system cells that transmit signals; glial cells support the neurons.

On the basis of the encouraging results with animal tissue, the team broadened its investigations to human umbilical cord matrix cells with similar exciting findings -- human umbilical cord matrix cells differentiate into neurons, too.

Most of the promise of developing embryonic stem cell-based therapies for treating several degenerative diseases of the nervous system as well as other types of disease is hindered by the controversial nature of the cell sources. Research progress has also been slowed by having a limited number of existing embryonic stem cell lines available for federally-funded medical research.

"Identifying a non-controversial source of primitive stem cells is a step in the right direction," Davis said.

Wharton’s jelly, discovered in the mid-1600s by Thomas Wharton, a London physician, is the gelatinous connective tissue only found in the umbilical cord. The jelly gives the cord resiliency and pliability, and protects the blood vessels in the umbilical cord from compression.

As an embryo forms, some very primitive cells migrate between the region where the umbilical cord forms and the embryo. Some primitive cells just might remain in the matrix later in gestation or still be there even after the baby is born.

The K-State research team suggests that Wharton’s jelly might be a reservoir of the primitive stem cells that form soon after the egg is fertilized.

Mitchell said, "Our results indicate that Wharton’s jelly cells can be expanded in vitro, maintained in culture and induced to differentiate into neural cells. We think these cells can serve many therapeutic and biotechnological roles in the future."

The team now is evaluating human umbilical cord matrix cells to see if in addition to forming nerve tissues the cells also will differentiate into cardiac muscle and the cells that line the blood vessels.

They note that important progress is being made in the Weiss and Troyer labs where the researchers are looking at the ability of the umbilical cord matrix cells to form new neurons in the brain in an animal model of Parkinson’s disease.

The KSU Research Foundation has filed for U.S. patent protection for the recent discoveries, the method of culturing the stem cells, and a kit for salvaging umbilical cord stem cells after birth.

Funding for this research has come from the National Institutes of Health, a Centers of Biomedical Research Excellence/COBRE award to the University of Kansas, with matching support from the state of Kansas, Kansas State University, University of Kansas, the K-State College of Veterinary Medicine and the Kansas Agricultural Experiment Station.



For patent and commercialization information, contact the Mid-America Commercialization Corporation, 785-532-3900; or send e-mail to macc@ksu.edu. For more about stem cells, see the National Institutes of Health primer at http://www.nih.gov/news/stemcell/primer.htm


Kathy E. Mitchell | EurekAlert!
Further information:
http://www.nih.gov/news/stemcell/primer.htm

More articles from Life Sciences:

nachricht Researchers identify potentially druggable mutant p53 proteins that promote cancer growth
09.12.2016 | Cold Spring Harbor Laboratory

nachricht Plant-based substance boosts eyelash growth
09.12.2016 | Fraunhofer-Institut für Angewandte Polymerforschung IAP

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electron highway inside crystal

Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.

Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

09.12.2016 | Life Sciences

Scientists produce a new roadmap for guiding development & conservation in the Amazon

09.12.2016 | Ecology, The Environment and Conservation

Satellites, airport visibility readings shed light on troops' exposure to air pollution

09.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>